As on Wednesday, Collegium Pharmaceutical Inc (NASDAQ: COLL) started slowly as it slid -3.92% to $30.18, before settling in for the price of $31.41 at the close. Taking a more long-term approach, COLL posted a 52-week range of $24.48-$42.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 17.87% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.66%. This publicly-traded company’s shares outstanding now amounts to $31.87 million, simultaneously with a float of $31.25 million. The organization now has a market capitalization sitting at $973.31 million. At the time of writing, stock’s 50-day Moving Average stood at $36.66, while the 200-day Moving Average is $35.50.
Collegium Pharmaceutical Inc (COLL) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Collegium Pharmaceutical Inc’s current insider ownership accounts for 3.11%, in contrast to 126.49% institutional ownership. According to the most recent insider trade that took place on Sep 13 ’24, this organization’s EVP and Chief Medical Officer sold 9,593 shares at the rate of 36.62, making the entire transaction reach 351,320 in total value, affecting insider ownership by 53,816.
Collegium Pharmaceutical Inc (COLL) Earnings and Revenue Records
Collegium Pharmaceutical Inc’s EPS increase for this current 12-month fiscal period is 12.66% and is forecasted to reach 6.58 in the upcoming year.
Collegium Pharmaceutical Inc (NASDAQ: COLL) Trading Performance Indicators
Let’s observe the current performance indicators for Collegium Pharmaceutical Inc (COLL). It’s Quick Ratio in the last reported quarter now stands at 0.88. The Stock has managed to achieve an average true range (ATR) of 1.54. Alongside those numbers, its PE Ratio stands at $13.02, and its Beta score is 0.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.62. Similarly, its price to free cash flow for trailing twelve months is now 5.06.
In the same vein, COLL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.32, a figure that is expected to reach 1.50 in the next quarter, and analysts are predicting that it will be 6.58 at the market close of one year from today.
Technical Analysis of Collegium Pharmaceutical Inc (COLL)
Through scrutinizing the latest numbers posted by the [Collegium Pharmaceutical Inc, COLL], it can be observed that its last 5-days Average volume of 0.72 million was better the volume of 0.44 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 11.03% While, its Average True Range was 1.61.
Raw Stochastic average of Collegium Pharmaceutical Inc (COLL) in the period of the previous 100 days is set at 3.89%, which indicates a major fall in contrast to 7.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.08% that was higher than 40.95% volatility it exhibited in the past 100-days period.
